2-(Pyrrolidin-1-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Catalog No. :
ACNIBM646
CAS No. :
1401350-36-4
Molecular Formula :
C15H23BN2O2
Molecular Weight :
274.17

IUPAC Name:2-(pyrrolidin-1-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-(Pyrrolidin-1-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Pyrrolidin-1-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
IUPAC Name2-(pyrrolidin-1-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MDL No.MFCD09607671
Molecular FormulaC15H23BN2O2
Molecular Weight274.17
SMILESCC1(C)C(C)(C)OB(C2=CC=CC(N3CCCC3)=N2)O1
InChI KeyLPILLXBRGKDUDL-UHFFFAOYSA-N
Synonym2-(1-pyrrolidinyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyridine;Pyridine, 2-(1-pyrrolidinyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1401350-36-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNIBM646 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUAPG129 route compound structure diagram
    ACUAPG129651358-83-7 In Stock
  4. Then
  5. ACNIBM646 route product structure diagram
    ACNIBM6461401350-36-4
Inquiry

2. ACNIBM646 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAUWP546 route compound structure diagram
    ACAUWP546652148-92-0 In Stock
  4. Then
  5. ACNIBM646 route product structure diagram
    ACNIBM6461401350-36-4
Inquiry

Comments (0)